The endogenous—neurotic distinction as a predictor of response to antidepressant drugs
- 1 February 1976
- journal article
- clinical trial
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 6 (1), 59-70
- https://doi.org/10.1017/s0033291700007509
Abstract
Synopsis: An inverse factor analysis of 880 depressed inpatients on 33 endogenous–neurotic variables yielded four patient types. Type 3 resembled the endogenous depressions and Type 2 the neurotic depressions. Type 3 patients responded well to both imipramine and chlorpromazine and did poorly on a placebo. Type 2 patients showed the greatest overall improvement at three weeks irrespective of treatment received, including a placebo.Keywords
This publication has 32 references indexed in Scilit:
- Depression Subtypes and Response to Phenelzine, Diazepam, and a PlaceboArchives of General Psychiatry, 1974
- Differential Response to Chlorpromazine, Imipramine, and PlaceboArchives of General Psychiatry, 1970
- A Comparative Trial of Imipramine, Amitriptyline, Isocarboxazid and Tranylcypromine in Out-Patient Depressive IllnessThe British Journal of Psychiatry, 1964
- A Controlled Clinical Trial of Imipramine (Tofranil) with Out-patientsThe British Journal of Psychiatry, 1963
- Statistical principles in experimental design.Published by American Psychological Association (APA) ,1962
- Imipramine (Tofranil) in Depressive States a Controlled Trial with In-PatientsJournal of Mental Science, 1961
- Treatment of Severe Depression by Imipramine (Tofranil)Journal of Mental Science, 1960
- A ward behavior rating scale for mental hospital patientsJournal of Clinical Psychology, 1960
- An inventory for assessing different kinds of hostility.Journal of Consulting Psychology, 1957
- Treatment of mental disorder.Published by American Psychological Association (APA) ,1953